Susquehanna Fundamental Investments’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,817
Closed -$2.1M 542
2025
Q4
$2.1M Hold
19,817
0.07% 241
2025
Q3
$2.52M Sell
19,817
-3,972
-17% -$473K 0.1% 209
2025
Q2
$2.92M Sell
23,789
-18,092
-43% -$2.07M 0.08% 272
2025
Q1
$4.24M Buy
41,881
+35,876
+597% +$3.5M 0.06% 354
2024
Q4
$555K Buy
+6,005
New +$590K 0.01% 836
2024
Q2
$971K Buy
+11,320
New +$950K 0.02% 566
2020
Q4
Sell
-18,013
Closed -$931K 1525
2020
Q3
$931K Buy
18,013
+8,460
+89% +$434K 0.03% 664
2020
Q2
$471K Buy
+9,553
New +$515K 0.02% 631

Other funds holding EHC

Susquehanna Fundamental Investments's EHC Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 19,817 shares — an estimated $2.1M sold.

Susquehanna Fundamental Investments first reported a position in EHC in Q2 2020 and held it in 8 quarters. The position peaked at $4.24M in Q1 2025. 580 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Susquehanna Fundamental Investments reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 19,817 Encompass Health shares in Q1 2026, an estimated $2.1M.
  • Susquehanna Fundamental Investments first reported a position in Encompass Health in Q2 2020 and held it in 8 quarters.
  • Susquehanna Fundamental Investments's Encompass Health position peaked at $4.24M in Q1 2025.
  • 580 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.